Cargando…

Characteristics of T‐cell responses in COVID‐19 patients with prolonged SARS‐CoV‐2 positivity – a cohort study

OBJECTIVE: SARS‐CoV‐2 has caused a worldwide pandemic of COVID‐19. The existence of prolonged SARS‐CoV‐2 positivity (PP) has further increased the burden on the health system. Since T cells are vital for viral control, we aimed to evaluate the characteristics of T‐cell responses associated with PP....

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jingyi, Zhong, Maohua, Hong, Ke, Yang, Qingyu, Zhang, Ejuan, Zhou, Dihan, Xia, Jianbo, Chen, Yao‐Qing, Sun, Mingbo, Zhao, Bali, Xiang, Jie, Liu, Ying, Han, Yang, Xu, Mengxin, Zhou, Xi, Huang, Chaolin, Shang, You, Yan, Huimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932004/
https://www.ncbi.nlm.nih.gov/pubmed/33728049
http://dx.doi.org/10.1002/cti2.1259
_version_ 1783660398718746624
author Yang, Jingyi
Zhong, Maohua
Hong, Ke
Yang, Qingyu
Zhang, Ejuan
Zhou, Dihan
Xia, Jianbo
Chen, Yao‐Qing
Sun, Mingbo
Zhao, Bali
Xiang, Jie
Liu, Ying
Han, Yang
Xu, Mengxin
Zhou, Xi
Huang, Chaolin
Shang, You
Yan, Huimin
author_facet Yang, Jingyi
Zhong, Maohua
Hong, Ke
Yang, Qingyu
Zhang, Ejuan
Zhou, Dihan
Xia, Jianbo
Chen, Yao‐Qing
Sun, Mingbo
Zhao, Bali
Xiang, Jie
Liu, Ying
Han, Yang
Xu, Mengxin
Zhou, Xi
Huang, Chaolin
Shang, You
Yan, Huimin
author_sort Yang, Jingyi
collection PubMed
description OBJECTIVE: SARS‐CoV‐2 has caused a worldwide pandemic of COVID‐19. The existence of prolonged SARS‐CoV‐2 positivity (PP) has further increased the burden on the health system. Since T cells are vital for viral control, we aimed to evaluate the characteristics of T‐cell responses associated with PP. METHODS: We established a PP cohort and two age‐ and sex‐matched control cohorts: a regular clinical recovery (CR) cohort and a healthy donor (HD) cohort. The mean time for RNA negativity conversion in the PP cohort was markedly longer than that in the CR cohort (66.2 vs 25.3 days), while the time from illness onset to sampling was not significantly different. T‐cell responses in the PP cohort were assayed, analysed and compared with those in the CR and HD cohorts by flow cytometry and ELISpot analysis of peripheral blood mononuclear cells. RESULTS: Compared with the CR cohort, the proliferation, activation and functional potential of CD8(+) and CD4(+) T cells in the PP cohort were not significantly different. However, the frequencies and counts of Teff and Tem in CD8(+) but not in CD4(+) T cells of the PP cohort were prominently lower. Moreover, a weaker SARS‐CoV‐2 N protein‐specific IFN‐γ(+) T‐cell response and a higher frequency of Tregs were detected in the PP cohort. CONCLUSION: Suppressed CD8(+) T‐cell differentiation is associated with PP and may be an indicator for the prediction of prolonged SARS‐CoV‐2 positivity in COVID‐19 patients. The association between suppressed CD8(+) T‐cell differentiation and elevated Tregs warrants studies in the future.
format Online
Article
Text
id pubmed-7932004
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-79320042021-03-15 Characteristics of T‐cell responses in COVID‐19 patients with prolonged SARS‐CoV‐2 positivity – a cohort study Yang, Jingyi Zhong, Maohua Hong, Ke Yang, Qingyu Zhang, Ejuan Zhou, Dihan Xia, Jianbo Chen, Yao‐Qing Sun, Mingbo Zhao, Bali Xiang, Jie Liu, Ying Han, Yang Xu, Mengxin Zhou, Xi Huang, Chaolin Shang, You Yan, Huimin Clin Transl Immunology Original Article OBJECTIVE: SARS‐CoV‐2 has caused a worldwide pandemic of COVID‐19. The existence of prolonged SARS‐CoV‐2 positivity (PP) has further increased the burden on the health system. Since T cells are vital for viral control, we aimed to evaluate the characteristics of T‐cell responses associated with PP. METHODS: We established a PP cohort and two age‐ and sex‐matched control cohorts: a regular clinical recovery (CR) cohort and a healthy donor (HD) cohort. The mean time for RNA negativity conversion in the PP cohort was markedly longer than that in the CR cohort (66.2 vs 25.3 days), while the time from illness onset to sampling was not significantly different. T‐cell responses in the PP cohort were assayed, analysed and compared with those in the CR and HD cohorts by flow cytometry and ELISpot analysis of peripheral blood mononuclear cells. RESULTS: Compared with the CR cohort, the proliferation, activation and functional potential of CD8(+) and CD4(+) T cells in the PP cohort were not significantly different. However, the frequencies and counts of Teff and Tem in CD8(+) but not in CD4(+) T cells of the PP cohort were prominently lower. Moreover, a weaker SARS‐CoV‐2 N protein‐specific IFN‐γ(+) T‐cell response and a higher frequency of Tregs were detected in the PP cohort. CONCLUSION: Suppressed CD8(+) T‐cell differentiation is associated with PP and may be an indicator for the prediction of prolonged SARS‐CoV‐2 positivity in COVID‐19 patients. The association between suppressed CD8(+) T‐cell differentiation and elevated Tregs warrants studies in the future. John Wiley and Sons Inc. 2021-03-04 /pmc/articles/PMC7932004/ /pubmed/33728049 http://dx.doi.org/10.1002/cti2.1259 Text en © 2021 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Article
Yang, Jingyi
Zhong, Maohua
Hong, Ke
Yang, Qingyu
Zhang, Ejuan
Zhou, Dihan
Xia, Jianbo
Chen, Yao‐Qing
Sun, Mingbo
Zhao, Bali
Xiang, Jie
Liu, Ying
Han, Yang
Xu, Mengxin
Zhou, Xi
Huang, Chaolin
Shang, You
Yan, Huimin
Characteristics of T‐cell responses in COVID‐19 patients with prolonged SARS‐CoV‐2 positivity – a cohort study
title Characteristics of T‐cell responses in COVID‐19 patients with prolonged SARS‐CoV‐2 positivity – a cohort study
title_full Characteristics of T‐cell responses in COVID‐19 patients with prolonged SARS‐CoV‐2 positivity – a cohort study
title_fullStr Characteristics of T‐cell responses in COVID‐19 patients with prolonged SARS‐CoV‐2 positivity – a cohort study
title_full_unstemmed Characteristics of T‐cell responses in COVID‐19 patients with prolonged SARS‐CoV‐2 positivity – a cohort study
title_short Characteristics of T‐cell responses in COVID‐19 patients with prolonged SARS‐CoV‐2 positivity – a cohort study
title_sort characteristics of t‐cell responses in covid‐19 patients with prolonged sars‐cov‐2 positivity – a cohort study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932004/
https://www.ncbi.nlm.nih.gov/pubmed/33728049
http://dx.doi.org/10.1002/cti2.1259
work_keys_str_mv AT yangjingyi characteristicsoftcellresponsesincovid19patientswithprolongedsarscov2positivityacohortstudy
AT zhongmaohua characteristicsoftcellresponsesincovid19patientswithprolongedsarscov2positivityacohortstudy
AT hongke characteristicsoftcellresponsesincovid19patientswithprolongedsarscov2positivityacohortstudy
AT yangqingyu characteristicsoftcellresponsesincovid19patientswithprolongedsarscov2positivityacohortstudy
AT zhangejuan characteristicsoftcellresponsesincovid19patientswithprolongedsarscov2positivityacohortstudy
AT zhoudihan characteristicsoftcellresponsesincovid19patientswithprolongedsarscov2positivityacohortstudy
AT xiajianbo characteristicsoftcellresponsesincovid19patientswithprolongedsarscov2positivityacohortstudy
AT chenyaoqing characteristicsoftcellresponsesincovid19patientswithprolongedsarscov2positivityacohortstudy
AT sunmingbo characteristicsoftcellresponsesincovid19patientswithprolongedsarscov2positivityacohortstudy
AT zhaobali characteristicsoftcellresponsesincovid19patientswithprolongedsarscov2positivityacohortstudy
AT xiangjie characteristicsoftcellresponsesincovid19patientswithprolongedsarscov2positivityacohortstudy
AT liuying characteristicsoftcellresponsesincovid19patientswithprolongedsarscov2positivityacohortstudy
AT hanyang characteristicsoftcellresponsesincovid19patientswithprolongedsarscov2positivityacohortstudy
AT xumengxin characteristicsoftcellresponsesincovid19patientswithprolongedsarscov2positivityacohortstudy
AT zhouxi characteristicsoftcellresponsesincovid19patientswithprolongedsarscov2positivityacohortstudy
AT huangchaolin characteristicsoftcellresponsesincovid19patientswithprolongedsarscov2positivityacohortstudy
AT shangyou characteristicsoftcellresponsesincovid19patientswithprolongedsarscov2positivityacohortstudy
AT yanhuimin characteristicsoftcellresponsesincovid19patientswithprolongedsarscov2positivityacohortstudy